VIVIMUSTA

Serial Number 97326086
Registration 7159025
700

Registration Progress

Application Filed
Mar 23, 2022
Under Examination
Apr 11, 2023
Approved for Publication
Feb 14, 2023
Published for Opposition
Feb 14, 2023
Registered
Sep 5, 2023

Trademark Image

VIVIMUSTA

Basic Information

Serial Number
97326086
Registration Number
7159025
Filing Date
March 23, 2022
Registration Date
September 5, 2023
Published for Opposition
February 14, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 5, 2023
Registration
Registered
Classes
005

Rights Holder

AZURITY PHARMACEUTICALS, INC.

03
Address
8 CABOT ROAD
SUITE 2000
WOBURN, MA 01801

Ownership History

Slayback Pharma Limited Liability Company

Original Applicant
16
Princeton, NJ

Slayback Pharma Limited Liability Company

Owner at Publication
16
Princeton, NJ

Slayback Pharma Limited Liability Company

Original Registrant
16
Princeton, NJ

AZURITY PHARMACEUTICALS, INC.

New Owner After Registration #1
03
WOBURN, MA

Legal Representation

Attorney
Douglas R. Wolf

USPTO Deadlines

Next Deadline
1353 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230905)
Due Date
September 05, 2029
Grace Period Ends
March 05, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

27 events
Date Code Type Description Documents
Mar 19, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Mar 5, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jul 16, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 16, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 16, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 16, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jul 16, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Sep 5, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Sep 5, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 18, 2023 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Aug 18, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 18, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 18, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 3, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Aug 2, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jul 10, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jun 9, 2023 IUAF S USE AMENDMENT FILED Loading...
Jul 10, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 9, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 11, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 14, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 14, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 25, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 9, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 5, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 29, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 26, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical products for the treatment of cancer
First Use Anywhere: Dec 7, 2022
First Use in Commerce: Dec 7, 2022

Classification

International Classes
005